Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$13,892,289
+$2,282,238 QoQ
Shares Held
55,207
+3.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#769
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAILARD, INC. holds $201,504,836 across 13 Drug Manufacturers - General names. ABBV ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
734,610 | $92,810,627 | |
| 2 | JNJ |
Johnson & Johnson
|
147,802 | $37,537,273 | |
| 3 | AMGN |
Amgen Inc
|
49,586 | $17,956,082 | |
| 4 | LLY |
ELI LILLY & Co
|
13,510 | $16,204,300 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
55,207 | $13,892,289 | |
| 6 | AZN |
Astrazeneca PLC
|
70,691 | $13,404,427 | |
| 7 | MRK |
Merck & Co., Inc.
|
26,669 | $3,426,966 | |
| 8 | NVS |
Novartis AG
|
13,869 | $2,173,549 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,892,289 | 55,207 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $11,610,051 | 53,382 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $12,851,648 | 56,246 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $10,501,033 | 45,353 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $5,439,408 | 29,304 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,689,856 | 17,611 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,103,175 | 17,463 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,457,479 | 17,508 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $2,999,541 | 17,488 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,781,306 | 20,765 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,243,677 | 20,931 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,147,103 | 21,113 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,856,410 | 21,201 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $4,454,869 | 27,953 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,515,868 | 27,943 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $3,757,208 | 27,995 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $4,297,669 | 28,060 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $4,581,228 | 28,260 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,932,828 | 29,046 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,046,896 | 28,246 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,176,560 | 28,201 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,233,397 | 29,878 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $660,365 | 6,163 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $522,999 | 5,971 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $824,221 | 8,395 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $578,815 | 7,597 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||